Alcohol Use Disorder Treatment Market Size, Share, Opportunities, And Trends By Type (Alcohol Abuse, Alcoholism (Alcohol dependence)), By Treatment (Medication, Behavioural Therapy), And Geography - Forecasts From 2019 to 2024

The alcohol use disorder treatment market is estimated to grow by US$6.750 billion in 2018. The growing demand for the alcohol use disorder treatment is mainly attributed to the prevalence of this disease worldwide, with the high prevalence reported in Eastern European countries, parts of South East Asia and selected countries in Americas. According to the estimates by the Institute of Medicine, in 1996 the prevalence of Fetal Alcohol Syndrome (FAS) in the United States was between 0.5 and 3.0 cases per 1,000. As per the recent reports from the specific U.S. sites, the prevalence of FAS was found to be 2 to 7 cases per 1,000, and the prevalence of Fetal Alcohol Spectrum Disorders (FASD) was estimated to be as high as 20 to 50 cases per 1,000 (Source: National Institutes of Health). Furthermore, the rising number of deaths occurring due to alcohol-related liver disease is driving the market growth during the forecast period.

 

Major industry players profiled as part of the report are Teva Pharmaceuticals USA, Inc., Adial Pharmaceuticals, Alkermes, ADDEX THERAPEUTICS, Kinnov Therapeutics, OPIANT PHARMACEUTICALS, INC, Ethypharm, and MONTISERA LTD.

 

Segmentation

The alcohol use disorder treatment market has been analyzed through following segments:

 

By Type

Alcohol Abuse

Alcoholism (Alcohol dependence)

 

By Treatment

Medication

Behavioural Therapy

 

By Geography

North America

USA

Canada

Mexico

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Spain

Others

 

Middle East and Africa

Saudi Arabia

Israel

Others

 

Asia Pacific

China

Japan

South Korea

India

Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY 

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Overview and Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Prevalence

4.5.1. By age group

4.5.2. By gender

4.5.3. By region

4.6. Product Pipeline

4.7. Innovations

5. ALCOHOL USE DISORDER TREATMENT MARKET BY TYPE

5.1. Alcohol Abuse

5.2. Alcoholism (Alcohol dependence)

6. ALCOHOL USE DISORDER TREATMENT MARKET BY TREATMENT

6.1. Medication

6.2. Behavioural Therapy

7. ALCOHOL USE DISORDER TREATMENT MARKET BY GEOGRAPHY

7.1. North America

7.1.1. USA

7.1.2. Canada

7.1.3. Mexico

7.2. South America

7.2.1. Brazil

7.2.2. Argentina

7.2.3. Others

7.3. Europe

7.3.1. Germany

7.3.2. France

7.3.3. United Kingdom

7.3.4. Spain

7.3.5. Others

7.4. Middle East and Africa

7.4.1. Saudi Arabia

7.4.2. Israel

7.4.3. Others

7.5. Asia Pacific

7.5.1. China

7.5.2. Japan

7.5.3. South Korea

7.5.4. India

7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1.  Competitive Benchmarking and Analysis

8.2.  Recent Investments and Deals

8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Teva Pharmaceuticals USA, Inc.

9.2. Adial Pharmaceuticals

9.3. Alkermes

9.4. ADDEX THERAPEUTICS

9.5. Kinnov Therapeutics

9.6. OPIANT PHARMACEUTICALS, INC

9.7. Ethypharm

9.8. MONTISERA LTD

LIST OF FIGURES

LIST OF TABLES

Teva Pharmaceuticals USA, Inc.

Adial Pharmaceuticals

Alkermes

ADDEX THERAPEUTICS

Kinnov Therapeutics

OPIANT PHARMACEUTICALS, INC

Ethypharm

MONTISERA LTD